|
1) Levy S, Sutton G, Ng PC, et al. The diploid genome sequence of an individual human. PLoS Biol. 2007; 5: e254
|
|
|
|
2) Wheeler DA, Srinivasan M, Egholm M, et al. The complete genome of an individual by massively parallel DNA sequencing. Nature. 2008; 452: 872-6
|
|
|
|
|
|
3) Wang J, Wang W, Li R, et al. The diploid genome sequence of an Asian individual. Nature. 2008; 456: 60-5
|
|
|
|
|
|
4) Fujimoto A, Nakagawa H, Hosono N, et al. Whole-genome sequencing and comprehensive variant analysis of a Japanese individual using massively parallel sequencing. Nat Genet. 2010; 42: 931-6
|
|
|
|
|
|
5) Hodges E, Xuan Z, Balija V, et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet. 2007; 39: 1522-7
|
|
|
|
|
|
6) Musunuru K, Pirruccello JP, Do R, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med. 2010; 363: 2220-7
|
|
|
|
|
|
7) Collins FS. Positional cloning: Letʼs not call it reverse genetics. Nat Genet. 1992; 1: 3-6
|
|
|
|
|
|
8) Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996; 273: 1516-7
|
|
|
|
|
|
9) Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science. 1997; 278: 1580-1
|
|
|
|
|
|
10) Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002; 32: 650-4
|
|
|
|
|
|
11) Tsuji S. Genetics of neurodegenerative diseases: insights from high-throughput resequencing. Hum Mol Genet. 2010; 19(R1): R65-70
|
|
|
|
|
|
12) Fukuda Y, Nakahara Y, Date H, et al. SNP HiTLink: a high-throughput linkage analysis system employing dense SNP data. BMC Bioinformatics. 2009; 10: 121
|
|
|
|
|
|
13) Ishiura H, Fukuda Y, Mitsui J, et al. Posterior column ataxia with retinitis pigmentosa in a Japanese family with a novel mutation in FLVCR1. Neurogenetics. 2011; 12: 117-21
|
|
|
|
|
|
14) Rajadhyaksha AM, Elemento O, Puffenberger EG, et al. Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. Am J Hum Genet. 2010; 87: 643-54
|
|
|
|
|
|
15) Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009; 461: 747-53
|
|
|
|
|
|
16) Mitsui J, Mizuta I, Toyoda A, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol. 2009; 66: 571-6
|
|
|
|
|
|
17) Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinsonʼs disease. N Engl J Med. 2009; 361: 1651-61
|
|
|
|
|
|
18) Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinsonʼs disease. Nat Genet. 2009; 41: 1303-7
|
|
|
|
|
|
19) Ng PC, Levy S, Huang J, et al. Genetic variation in an individual human exome. PLoS Genet. 2008; 4: e1000160
|
|
|
|
|
|
20) Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009; 106: 19096-101
|
|
|
|
|
|
21) Li H, Ruan J, Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008; 18: 1851-8
|
|
|
|
|
|
22) Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet. 2010; 375: 1525-35
|
|
|
|
|
|
23) Ormond KE, Wheeler MT, Hudgins L, et al. Challenges in the clinical application of whole-genome sequencing. Lancet. 2010; 375: 1749-51
|
|
|
|
|